Corbus Pharmaceuticals (NASDAQ:CRBP) Downgraded by StockNews.com
StockNews.com cut shares of Corbus Pharmaceuticals (NASDAQ:CRBP – Free Report) from a hold rating to a sell rating in a report published on Wednesday. Other equities analysts have also issued research reports about the stock. Royal Bank of Canada increased their target price on shares of Corbus Pharmaceuticals from $77.00 to $82.00 and gave the […]
More Stories
Atlanticus (NASDAQ:ATLC) Reaches New 12-Month High – Time to Buy?
Atlanticus Holdings Co. (NASDAQ:ATLC – Get Free Report)’s share price reached a new 52-week high on Tuesday . The company...
Payoneer Global (NASDAQ:PAYO) Hits New 52-Week High – Should You Buy?
Shares of Payoneer Global Inc. (NASDAQ:PAYO – Get Free Report) hit a new 52-week high during trading on Tuesday ....
iShares Bitcoin Trust (NASDAQ:IBIT) Sets New 1-Year High – Here’s What Happened
iShares Bitcoin Trust (NASDAQ:IBIT – Get Free Report) shares hit a new 52-week high on Tuesday . The company traded...
TKO Group (NYSE:TKO) Hits New 12-Month High – Here’s Why
TKO Group Holdings, Inc. (NYSE:TKO – Get Free Report) shares hit a new 52-week high during trading on Tuesday ....
News from the WHO: WHO adds LC16m8 mpox vaccine to Emergency Use Listing https://ift.tt/6aJzo5E November 19, 2024 at 07:00AM
Published on November 19, 2024 at 07:00AM View on website
Keysight Technologies (NYSE:KEYS) Releases Q1 Earnings Guidance
Keysight Technologies (NYSE:KEYS – Get Free Report) updated its first quarter earnings guidance on Tuesday. The company provided EPS guidance...